Compare PRGS & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRGS | AORT |
|---|---|---|
| Founded | 1981 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 1995 | 1996 |
| Metric | PRGS | AORT |
|---|---|---|
| Price | $45.09 | $22.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $56.20 | $40.91 |
| AVG Volume (30 Days) | ★ 557.2K | 450.9K |
| Earning Date | 09-30-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 7.79 | ★ 165.62 |
| EPS | ★ 1.58 | N/A |
| Revenue | ★ $397,572,000.00 | $298,836,000.00 |
| Revenue This Year | $7.13 | $11.17 |
| Revenue Next Year | $22.19 | $10.80 |
| P/E Ratio | $28.24 | ★ N/A |
| Revenue Growth | N/A | ★ 18.01 |
| 52 Week Low | $23.82 | $19.16 |
| 52 Week High | $47.25 | $48.25 |
| Indicator | PRGS | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 62.85 | 45.35 |
| Support Level | $35.97 | $21.76 |
| Resistance Level | $46.36 | $24.08 |
| Average True Range (ATR) | 1.61 | 0.93 |
| MACD | 0.42 | 0.18 |
| Stochastic Oscillator | 78.41 | 42.09 |
Progress Software Corp provides software products that enable customers to develop, deploy, and manage AI-powered applications and digital experiences. The Company operates across North America, Latin America, Europe, the Middle East and Africa (EMEA), and Asia Pacific through subsidiaries and distributors, generating a majority of its revenue from the United States. Its product portfolio includes Progress Agentic RAG, Automate MFT, Chef, Corticon, DataDirect, Developer Tools, Flowmon, Kemp LoadMaster, MarkLogic, MOVEit, OpenEdge, Semaphore, ShareFile, Sitefinity, and WhatsUp Gold, offering solutions for application development, data connectivity, DevOps automation, managed file transfer, network security, and digital experience. It generates maximum revenue from the United States.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.